Second Affiliated Hospital of medical college of Xi'an JiaoTong University

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression	interstitial lung disease, lung disorder, respiratory system disorder	Recruiting	Phase 3	2026-10-01	NCT07540988
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis	Metabolic Dysfunction Associated Steatohepatitis	Recruiting	Phase 3	2026-10-01	NCT06632457
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis	Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder	Recruiting	Phase 3	2026-10-01	NCT06632444
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast	idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder	Active, not recruiting	Phase 3	2026-09-30	NCT06238622
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum	Skin Ulcer, Skin and Connective Tissue Diseases, pyoderma, pyoderma gangrenosum, skin disorder, skin vascular disease	Recruiting	Phase 3	2026-09-02	NCT06624670

Clinical trials